Associate Chief Physician Adjunct Professor, Shanghai Jiao Tong University - University of Ottawa Joint School of Medicine Specializes in surgical diagnosis and treatment of cardiac and vascular diseases, particularly endovascular minimally invasive diagnosis and treatment of great vessel diseases, valvular heart disease, and congenital heart disease. Graduated in 2004 from Shanghai Jiao Tong University School of Medicine (formerly Shanghai Second Medical University) with a degree in Clinical Medicine. Upon graduation, joined the Department of Cardiovascular Surgery at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, serving as Associate Chief Physician and Teaching Director. Received specialized training in Transcatheter Aortic Valve Replacement (TAVR) in France from 2013 to 2014. Received specialized training in clinical medical education in Canada in 2016. Utility Model Patent: "Aortic Stent Assembly" (one patent) Aug 2021 - Jul 2023: MicroPort Group "Medical-Engineering Collaboration Project Fund" - Design and Development of a Novel Arch Stent, participant Dec 2021 - Nov 2024: Pudong New Area Health Commission Research Project - Industry Special Project - Regional Integrated Diagnosis and Treatment System for Acute Aortic Diseases, participant Aug 2020 - Jan 2022: Prospective, Multicenter, Single-Arm Objective Performance Criteria Clinical Study Evaluating the Safety and Efficacy of a Single Inner Branch Thoracic Aortic Stent-Graft System for the Treatment of Stanford Type B Aortic Dissection Involving the Proximal Left Subclavian Artery, participant As a new-generation hybrid cardiovascular surgeon, has long been engaged in endovascular minimally invasive diagnosis and treatment of cardiac and vascular diseases. Not only proficient in classic open-heart surgery under cardiopulmonary bypass, but also features transcatheter minimally invasive intervention as a technical specialty: independently performs coronary angiography; independently performs interventional treatment of congenital heart disease; independently performs total endovascular stent repair and branch reconstruction for complex great vessel diseases, with an original in situ fenestration technique for the left subclavian artery - the JD method; Hybrid composite aortic surgery; independently performs interventional treatment of various structural heart diseases as the primary operator, including transcatheter aortic valve implantation (TAVI) via all approaches.